Jose Lutzky on Proactively Monitoring Patients Receiving Immunotherapy Treatments
Jose Lutzky, MD, discusses the importance of proactive patient monitoring with patients receiving immunotherapy treatments.
Jose Lutzky, MD, from Mount Sinai Medical Center, discusses the best practices for monitoring patients on immunotherapy.
With treatments that are potentially very toxic, it is important to develop a plan for following up with the patients. Every patient is different and some will need closer monitoring than others. Nurses shouldn’t rely on the patient to reach out to them, either. For treatments that could possibly result in these kinds of adverse events, it is better to take a more proactive approach to patient monitoring.
Stopping ICIs at 1 or 2 Years May Not Compromise Survival in HNSCC
September 11th 2024This retrospective, population-based study shows strong efficacy across multiple patient subgroups and different lines of therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.
